Earnings per share for the last twelve months: Aadi Bioscience, Inc. (WHWK)

Graphic logo of Aadi Bioscience (WHWK)

The stability of the US jurisdiction protects Aadi Bioscience Inc (WHWK) from external risks, as confirmed by the time trajectory on the GURU.Markets chart. The rolling annual earnings per share demonstrate momentum driven by the use of nanoparticles to combat rare tumors. A team of mTOR inhibitor experts supports this growth, with -1.08 serving as the current metric level.

WHWK (Aadi Bio) Net earnings per one share for the last twelve months history from 03/20/2025 to 11/12/2026

Summary analytical data breakdowns for Aadi Bioscience, Inc. (WHWK)

- share price and expert price forecast:
Stock Quotes Aadi Bio|WHWK - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Aadi Bioscience Inc|WHWK - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Book Value per Share Aadi Bioscience|WHWK - Total Stockholders' Equity|Market Capitalization to Book Value Ratio aadibio.com|WHWK - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Aadi Bioscience Inc|WHWK - Long-Term Debt to Capital|Short-Term Debt to Capital Aadi Bio|WHWK - Company Aggregate Debt|Debts to Book Capitalization Aadi Bioscience Inc|WHWK - Long-Term Debt Volume|Company Current Liabilities Aadi Bioscience|Quick Ratio aadibio.com
- net income and valuation multiples indicators:
WHWK - Company Net Income|Projected Future Earnings Aadi Bioscience Inc|WHWK - Business Payback Period|Future Price to Earnings Aadi Bio|WHWK - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aadi Bioscience Inc|WHWK - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Aadi Bioscience|WHWK - Net earnings per share for the last 12 months|Quarterly EPS earnings growth aadibio.com|WHWK - Expected net earnings per share growth this year|Earnings growth forecast for next year Aadi Bioscience Inc
Fundamental valuation:aadibio.com (WHWK)
Manufactured products of Aadi Bioscience, Inc.

Fundamental analysis allows for the elimination of market noise and an objective assessment of business value. This is critical for Aadi Bioscience Inc (WHWK), as the reduction in research and the depletion of cash reserves impact solvency. The calculation of annual net income per share, reflected through the company's 12-month earnings per share, demonstrates real capital efficiency. The trend of this metric reveals the cash burn rate, helping investors recognize the risk of equity dilution in a timely manner.

Competitors of Aadi Bioscience Inc

ONC: Net earnings per share for the last 12 months|HALO - Net earnings per share (EPS TTM)|Revolution Medicines, Inc. (RVMD) - Earnings per share for the last twelve months|Ascentage Pharma Group International - Earnings per share for the trailing year|CGON (CG Oncology Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months UroGen Pharma Corp URGN|Net earnings per share (EPS TTM) BCAX|Net earnings per share (EPS TTM) personalis.com (PSNL)|Net earnings per share (EPS TTM) ERAS (Erasca)|Net earnings per share (EPS TTM) Delcath Systems Inc DCTH|YmAbs - Net earnings per share (EPS TTM)|AURA (Aura Corp) - Earnings per share for the last 12 months|CADL: Net earnings per share (EPS TTM)|ARAY - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months SLS|ACTU: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CTOR|Earnings per share for the last twelve months HURA (tuhurabio.com)|Net earnings per share (EPS TTM) TARA (Protara Therapeutics)|Net earnings per share for the last four quarters fatetherapeutics.com (FATE)|TCRX - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Champions Oncology|xbiotech.com (XBIT) - Earnings per share for the last twelve months|CVM - Net earnings per share for the last four quarters|OSTX (OS Therapies Incorporated) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months radiopharmtheranostics.com (RADX)|Net earnings per share (EPS TTM) ARTV|Net earnings per share for the last four quarters adlainortye.com|Net earnings per share (EPS TTM) VERU (Veru Pharma)|Tempest Therapeutics Corp (TPST) - Net earnings per one share for the last twelve months|XLO - Earnings per share for the last twelve months|RENB (Renovaro Inc.) - Earnings per share for the last 12 months|MURA: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Kairos Pharma|OKUR (OnKure Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months CytoMed GDTC|Net earnings per share for the last 12 months CRIS (Curis, Inc.)|APLM (apollomicsinc.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) THAR (Tharimmune)|Net earnings per share for the last four quarters Advanced Biomed Inc. (ADVB)|GNPX - Earnings per share for the last twelve months|CLDI (Calidi Biotherapeutics) - Earnings per share for the last 12 months|SBFM: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Xenetic Biosciences, Inc.|Net earnings per share for the last 12 months SLRX|Net earnings per share for the last 12 months Purple Biotech Ltd (PPBT)|Net earnings per share (EPS TTM) AONC|BGNE (BeiGene Ltd) - Earnings per share for the trailing year|Checkpoint Therapeutics - Net earnings per share for the last 12 months|ELEV - Net earnings per share for the last 12 months|ICAD - Earnings per share for the last twelve months|IKNA - Net earnings per share (EPS TTM)|NTBL: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Viracta Therapeutics, Inc.|MOR (MorphoSys AG) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) nayabiosciences.com|Earnings per share for the last twelve months Ascentage Pharma (AAPGV)